NCT01636609 2020-04-13
Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
Phase 1 Terminated
Clinical Trials
7 trialsNCT02352831 2019-08-28
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Washington University School of Medicine
Phase 1/2 Terminated
NCT00522938 2012-06-28
Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Chroma Therapeutics
Phase 1/2 Terminated
NCT00780598 2012-06-28
OPAL
Chroma Therapeutics
Phase 2 Completed
NCT00737555 2012-02-15
A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours
Chroma Therapeutics
Phase 1 Completed
NCT01180426 2012-02-15
Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia
Chroma Therapeutics
Phase 2 Unknown
NCT00689000 2010-10-22
Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
Chroma Therapeutics
Phase 1/2 Completed